Sorry, typo should have read as 60% franking.
Dot points below
•COCHLEAR POSTS RECORD FIRST-HALF REVENUE; NEW IMPLANT
RECIPIENTS AT ALL-TIME HIGH; RECALL COSTS FULLY EXPENSED
•Total revenue up 3% to $387.5 million, with sales up 5% in constant currency Net Loss of $20.4 million after $100.5 million after-tax recall costs fully expensed Final dividend of $1.20 per share (60% franked), up 14% on the prior year
•Cochlear implant unit sales of 10,724 units: while this is down 9%, it excludes over 2,300 implant units shipped post recall and not recognised as revenue
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$318.95 |
Change
2.060(0.65%) |
Mkt cap ! $20.85B | |||
| Open | High | Low | Value | Volume |
| $318.03 | $319.07 | $314.87 | $9.541M | 30.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3 | $318.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $318.95 | 25 | 9 |
View Market Depth
| Last trade - 13.56pm 31/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |